(Q46771283)

25 December 2017

title

T-817MA, a novel neurotrophic compound, ameliorates phencyclidine-induced disruption of sensorimotor gating (English)

1 reference

25 December 2017

author name string

Tomonori Seo

1

1 reference

25 December 2017

Tomiki Sumiyoshi

2

1 reference

25 December 2017

Masahiko Tsunoda

3

1 reference

25 December 2017

Kodai Tanaka

4

1 reference

25 December 2017

Takashi Uehara

5

1 reference

25 December 2017

Tadasu Matsuoka

6

1 reference

25 December 2017

Hiroko Itoh

7

1 reference

25 December 2017

Masayoshi Kurachi

8

1 reference

25 December 2017

publication date

5 February 2008

1 reference

25 December 2017

number of pages

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

25 December 2017

volume

197

1 reference

25 December 2017

issue

3

1 reference

25 December 2017

page(s)

457-464

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-007-1057-8

exact match

0 references

cites work

Sensorimotor gating and schizophrenia. Human and animal model studies

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-1057-8

Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-1057-8

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-1057-8

Implications of normal brain development for the pathogenesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-1057-8

21 January 2018

1 reference

12 December 2020

Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-beta peptide (1-40) in rats.

1 reference

12 December 2020

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

1 reference

12 December 2020

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

1 reference

12 December 2020

The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs

1 reference

12 December 2020

Effects of LU-111995 in three models of disrupted prepulse inhibition in rats

1 reference

12 December 2020

"Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits

1 reference

12 December 2020

Presidential Address, 1974. The more or less startling effects of weak prestimulation

1 reference

12 December 2020

Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents

1 reference

12 December 2020

Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex

1 reference

12 December 2020

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

1 reference

12 December 2020

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

1 reference

12 December 2020

Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat.

1 reference

12 December 2020

Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.

1 reference

12 December 2020

Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

1 reference

12 December 2020

Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex.

1 reference

12 December 2020

Dopaminergic stimulation disrupts sensorimotor gating in the rat

1 reference

12 December 2020

Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex.

1 reference

12 December 2020

T-817MA, a novel neurotrophic agent, improves sodium nitroprusside-induced mitochondrial dysfunction in cortical neurons.

1 reference

12 December 2020

Animal behavior models of the mechanisms underlying antipsychotic atypicality

1 reference

12 December 2020

Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats

1 reference

12 December 2020

Ventral pallidal GABA-A receptors regulate prepulse inhibition of acoustic startle

1 reference

12 December 2020

Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors

1 reference

12 December 2020

Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics.

1 reference

12 December 2020

Antipsychotic drug effects on brain morphology in first-episode psychosis

1 reference

12 December 2020

A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons

1 reference

12 December 2020

Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia.

1 reference

12 December 2020

Mechanisms of N-methyl-D-aspartate-induced apoptosis in phencyclidine-treated cultured forebrain neurons

1 reference

12 December 2020

Pathogenesis of schizophrenia: Part I. Symptomatology, cognitive characteristics and brain morphology

1 reference

12 December 2020

The effect of hypertension and obesity on the development of diabetes mellitus in patients treated with atypical antipsychotic drugs

1 reference

12 December 2020

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

1 reference

12 December 2020

A comparison of incidence of diabetes mellitus between atypical antipsychotic drugs: a survey for clozapine, risperidone, olanzapine, and quetiapine

1 reference

12 December 2020

Partial reversal of phencyclidine-induced impairment of prepulse inhibition by secretin

1 reference

12 December 2020

The acoustic startle response in rats--circuits mediating evocation, inhibition and potentiation

1 reference

12 December 2020

Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.

1 reference

12 December 2020

Chronic phencyclidine administration induces schizophrenia-like changes in N-acetylaspartate and N-acetylaspartylglutamate in rat brain

1 reference

12 December 2020

Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats.

1 reference

12 December 2020

Prestimulus effects on human startle reflex in normals and schizophrenics

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Study of a new schizophrenomimetic drug; sernyl.

1 reference

12 December 2020

Pathogenesis of schizophrenia: Part II. Temporo-frontal two-step hypothesis

1 reference

12 December 2020

Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats

1 reference

12 December 2020

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

12 December 2020

Disruption of prepulse inhibition in mice lacking mGluR1.

1 reference

12 December 2020

NMDA receptor hypofunction model of schizophrenia

1 reference

12 December 2020

Acoustic and temporal factors in the evocation of startle

1 reference

12 December 2020

Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex.

1 reference

12 December 2020

Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats

1 reference

12 December 2020

Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition

1 reference

12 December 2020

mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.

1 reference

12 December 2020

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

1 reference

12 December 2020

Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating

1 reference

12 December 2020

Clozapine enhances disruption of prepulse inhibition after sub-chronic dizocilpine- or phencyclidine-treatment in Wistar rats.

1 reference

12 December 2020

Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors

1 reference

12 December 2020

10.1007/S00213-007-1057-8

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

18251012

1 reference

25 December 2017